{"transactions":[{"id":3000483,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T16:03:48.000Z","date":"2020-10-21","kind":"grant","acquired":true,"shares":2485,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2485,"source":{"system":"sec-edgar","filing":"0001104659-20-117709","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000110465920117709/a4.xml","form_type":"4"}},{"id":3103986,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T16:28:49.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on June 18, 2021."}],"balance_after":9600,"derivative":{"exercise_price":11.45,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-20-075260","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000110465920075260/a4.xml","form_type":"4"}},{"id":3237344,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Product Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-02T15:38:24.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":21719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":21719,"derivative":{"exercise_price":51.81,"expiration_date":"2030-02-27","underlying":"Ordinary Shares","underlying_shares":21719},"source":{"system":"sec-edgar","filing":"0000904454-20-000251","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445420000251/edgar.xml","form_type":"4"}},{"id":3237343,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Product Dev."}}],"security":"Ordinary Shares","published_at":"2020-03-02T15:38:24.000Z","date":"2020-02-27","kind":"grant","acquired":true,"shares":12380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":61599,"source":{"system":"sec-edgar","filing":"0000904454-20-000251","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445420000251/edgar.xml","form_type":"4"}},{"id":3296379,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Product Dev."}}],"security":"Ordinary Shares","published_at":"2020-01-31T16:13:05.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":6092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance-based restricted share units (\"PRSUs\") granted on January 25, 2019 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 31, 2020.  Each PRSU represents the contingent right to receive one Ordinary Share."}],"balance_after":49219,"source":{"system":"sec-edgar","filing":"0000904454-20-000132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445420000132/edgar.xml","form_type":"4"}},{"id":3297618,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Product Dev."}}],"security":"Ordinary Shares","published_at":"2020-01-30T21:11:04.000Z","date":"2020-01-28","kind":"sale","acquired":false,"shares":923,"price":62.1,"value":57318.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.85 to $61.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":43127,"source":{"system":"sec-edgar","filing":"0000904454-20-000114","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445420000114/edgar.xml","form_type":"4"}},{"id":3297617,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Product Dev."}}],"security":"Ordinary Shares","published_at":"2020-01-30T21:11:04.000Z","date":"2020-01-28","kind":"sale","acquired":false,"shares":1304,"price":61.27,"value":79896.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.85 to $61.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":44050,"source":{"system":"sec-edgar","filing":"0000904454-20-000114","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445420000114/edgar.xml","form_type":"4"}},{"id":3321599,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T16:03:32.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on December 18, 2020."}],"balance_after":9600,"derivative":{"exercise_price":9.96,"expiration_date":"2029-12-18","underlying":"Common Stock","underlying_shares":9600},"source":{"system":"sec-edgar","filing":"0001104659-20-000850","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000110465920000850/a4.xml","form_type":"4"}},{"id":3409668,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Product Dev."}}],"security":"Ordinary Shares","published_at":"2019-09-19T09:39:07.000Z","date":"2019-09-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect the inadvertent overstatement of the Reporting Person's holdings by 100 shares in his last Form 4 filed on 01/30/2019."}],"balance_after":45354,"source":{"system":"sec-edgar","filing":"0000904454-19-000642","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445419000642/edgar.xml","form_type":"4"}},{"id":3549904,"issuer":{"id":15295,"kind":"organization","name":"HOOKIPA Pharma Inc.","symbol":"HOOK"},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-24T17:32:47.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":19200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on April 17, 2020, with the remainder vesting in 8 equal quarterly installments thereafter."}],"balance_after":19200,"derivative":{"exercise_price":14,"expiration_date":"2029-04-17","underlying":"Common Stock","underlying_shares":19200},"source":{"system":"sec-edgar","filing":"0001104659-19-023443","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000110465919023443/a4.xml","form_type":"4"}},{"id":3682378,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-30T17:01:38.000Z","date":"2019-01-28","kind":"sale","acquired":false,"shares":1358,"price":31.31,"value":42518.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.26 to $31.39. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Shares held by SJH van Deventer C.V., an entity affiliated with Forbion Capital Partners (\"FCP\"), or required to be transferred to FCP under the Reporting Person's employment agreement with FCP. The Reporting Person\nhas a partial beneficial interest in such shares as a managing partner of FCP, however he disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":40313,"source":{"system":"sec-edgar","filing":"0000904454-19-000126","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445419000126/edgar.xml","form_type":"4"}},{"id":3683478,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-29T20:47:34.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":18325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":18325,"derivative":{"exercise_price":31.71,"expiration_date":"2029-01-25","underlying":"Ordinary Shares","underlying_shares":18325},"source":{"system":"sec-edgar","filing":"0000904454-19-000115","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445419000115/edgar.xml","form_type":"4"}},{"id":3683477,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-29T20:47:34.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":10913,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance-based restricted share units (\"PRSUs\") granted on January 26, 2018 to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated, which vested on January 25, 2019.  Each PRSU represents the contingent right to receive one Ordinary Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by SJH van Deventer C.V., an entity affiliated with Forbion Capital Partners (\"FCP\"), or required to be transferred to FCP under the Reporting Person's employment agreement with FCP.  The Reporting Person has a partial beneficial interest in such shares as a managing partner of FCP, however he disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":41571,"source":{"system":"sec-edgar","filing":"0000904454-19-000115","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445419000115/edgar.xml","form_type":"4"}},{"id":3683476,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-29T20:47:34.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":5589,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by SJH van Deventer C.V., an entity affiliated with Forbion Capital Partners (\"FCP\"), or required to be transferred to FCP under the Reporting Person's employment agreement with FCP.  The Reporting Person has a partial beneficial interest in such shares as a managing partner of FCP, however he disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":30658,"source":{"system":"sec-edgar","filing":"0000904454-19-000115","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445419000115/edgar.xml","form_type":"4"}},{"id":4083314,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-01-31T10:42:48.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":5985,"price":18.53,"value":110902.05,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.41 to $18.69. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by SJH van Deventer C.V., an entity affiliated with Forbion Capital Partners (\"FCP\"), or required to be transferred to FCP under the Reporting Person's employment agreement with FCP.  The Reporting Person has a partial beneficial interest in such shares as a managing partner of FCP, however he disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":25069,"source":{"system":"sec-edgar","filing":"0000904454-18-000093","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445418000093/edgar.xml","form_type":"4"}},{"id":4084639,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-30T13:11:05.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":20788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":20788,"derivative":{"exercise_price":19.39,"expiration_date":"2028-01-26","underlying":"Ordinary Shares","underlying_shares":20788},"source":{"system":"sec-edgar","filing":"0000904454-18-000084","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445418000084/edgar.xml","form_type":"4"}},{"id":4084638,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-01-30T13:11:05.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":7795,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote (2)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 9,859 Ordinary Shares held by SJH van Deventer C.V., an entity affiliated with Forbion Capital Partners (\"FCP\").  The Reporting Person has a partial beneficial interest in such shares as a managing partner of FCP, however he disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. (ii) 5,000 restricted share units that vested in full on January 27, 2017 previously disclosed by the Reporting Person in Table II; and (iii) 11,000 restricted share units that vested in full on January 27, 2018 previously disclosed by the Reporting Person in Table II.  Under the Reporting Person's employment agreement with FCP, he is required to transfer the restricted share units to FCP. The Reporting Person has a partial beneficial interest in such restricted share units as a managing partner of FCP, however he disclaims beneficial ownership of such restricted share units except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Adjusted to reflect the sale on January 30, 2017 of 2,600 shares to satisfy tax withholding obligations in connection with the vesting of restricted share units, the proceeds of which were remitted to the Issuer, as required by the relevant Restricted Share Unit Agreement."}],"balance_after":31054,"source":{"system":"sec-edgar","filing":"0000904454-18-000084","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000090445418000084/edgar.xml","form_type":"4"}},{"id":4202951,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-22T16:34:12.000Z","date":"2017-09-20","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first tranche of 25% vests on September 20, 2018, with the remainder vesting in tranches of 6.25% each quarter thereafter over three years."}],"balance_after":150000,"derivative":{"exercise_price":8.49,"expiration_date":"2027-09-20","underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-053713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000120919117053713/doc4.xml","form_type":"4"}},{"id":4474982,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-01-31T15:17:13.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Managing Partner"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Unit vests 100% on January 27, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vests."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Under Mr. van Deventer's employment agreement with Forbion Capital Partners, he is required to transfer the Restricted Stock Units and stock options to Forbion Capital Partners. As a managing partner of Forbion Capital Partners, Mr. van Deventer has a partial beneficial interest in the Restricted Stock Units and stock options transferred to Forbion Capital Partners. Mr. van Deventer disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":16000,"derivative":{"exercise_price":0,"exercise_date":"2020-01-27","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001140361-17-003707","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000114036117003707/doc1.xml","form_type":"4"}},{"id":4474981,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T15:17:13.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Managing Partner"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests 100% on January 27, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Under Mr. van Deventer's employment agreement with Forbion Capital Partners, he is required to transfer the Restricted Stock Units and stock options to Forbion Capital Partners. As a managing partner of Forbion Capital Partners, Mr. van Deventer has a partial beneficial interest in the Restricted Stock Units and stock options transferred to Forbion Capital Partners. Mr. van Deventer disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":11000,"derivative":{"exercise_price":5.37,"expiration_date":"2027-01-27","underlying":"Ordinary Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001140361-17-003707","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1543084/000114036117003707/doc1.xml","form_type":"4"}},{"id":4485499,"issuer":{"id":167312,"kind":"organization","name":"ARGOS THERAPEUTICS INC","symbol":"ARGS"},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-20T13:46:15.000Z","date":"2017-01-19","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9500,"derivative":{"exercise_price":4.85,"exercise_date":"2017-01-19","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001543084-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105533/000154308417000001/primary_doc.xml","form_type":"4"}},{"id":4590541,"issuer":{"id":167312,"kind":"organization","name":"ARGOS THERAPEUTICS INC","symbol":"ARGS"},"owners":[{"id":145762,"kind":"person","name":"van Deventer Sander","position":1,"cik":"0001543084","reported_name":"van Deventer Sander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-03T11:28:06.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":2263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock."}],"balance_after":5057,"source":{"system":"sec-edgar","filing":"0001543084-16-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105533/000154308416000005/primary_doc.xml","form_type":"4"}}]}